Literature DB >> 20924037

Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis.

Haeryoung Kim1, Joo-Yeon Song, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han, Hye Seung Lee, Han Suk Ryu, Gheeyoung Choe.   

Abstract

AIM: The significance of cell cycle proteins, p21 and p53, and cyclo-oxygenase-2 (COX2) is still controversial in gallbladder adenocarcinoma. Conflicting results exist with regard to the prognostic significance of p21 and p53 expression, and the strong association of gallbladder cancer with chronic inflammation makes it only natural that COX2 negativity is rarely encountered, even in non-neoplastic biliary epithelia.
METHODS: The authors explored whether the p21 and p53-labelling indices (LI) and strong cytoplasmic COX2 expression differ in the central parts (TC) and invasive fronts (IF) of gallbladder cancer. Paraffin-embedded whole tissue sections of 67 gallbladder cancers were immunohistochemically analysed for p21, p53 and COX2-LI at the IF and TC, and results were correlated with the clinicopathological features.
RESULTS: Significantly higher LI was seen in IF compared with TC for p21, p53 and COX2. COX2-LI-IF showed significant positive correlations with perineural and lymphatic invasion, higher T and N stages, and non-papillary gross morphology. Gall-bladder cancers with COX2-LI-IF≥30% showed decreased overall and disease-free survival, and COX2-LI-IF≥30% was an independent poor prognostic factor on multivariable analysis. Gall-bladder cancers with high COX2 and p21-LI-IF showed decreased overall and disease-free survival.
CONCLUSIONS: The IF of gallbladder cancer is characterised by significantly increased expression of p21, p53 and strong COX2 expression, and strong cytoplasmic COX2 expression at IF is associated with a poorer prognosis. Heterogeneity between TC and IF should be considered in in situ molecular studies, especially during interpretation of immunohistochemical stain results and tissue microarray construction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20924037     DOI: 10.1136/jcp.2010.080713

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

Review 1.  The inflammatory inception of gallbladder cancer.

Authors:  Jaime A Espinoza; Carolina Bizama; Patricia García; Catterina Ferreccio; Milind Javle; Juan F Miquel; Jill Koshiol; Juan C Roa
Journal:  Biochim Biophys Acta       Date:  2016-03-12

Review 2.  Gallbladder cancer: Clinical and pathological approach.

Authors:  Keita Kai; Shinichi Aishima; Kohji Miyazaki
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

3.  Cadmium exposure activates Akt/ERK Signaling and pro-inflammatory COX-2 expression in human gallbladder epithelial cells via a ROS dependent mechanism.

Authors:  Priyanka Sharma; Trevar S Caldwell; Megan N Rivera; Rama R Gullapalli
Journal:  Toxicol In Vitro       Date:  2020-06-06       Impact factor: 3.500

Review 4.  Molecular genetics and targeted therapeutics in biliary tract carcinoma.

Authors:  Eric I Marks; Nelson S Yee
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

5.  Cyclooxygenase-2 expression and its prognostic significance in clear cell renal cell carcinoma.

Authors:  Ji Won Lee; Jeong Hwan Park; Ja Hee Suh; Kyung Han Nam; Ji-Young Choe; Hae Yoen Jung; Ji Yoen Chae; Kyung Chul Moon
Journal:  Korean J Pathol       Date:  2012-06-22

6.  Evaluation of P53, E-cadherin, Cox-2, and EGFR protein immunoexpression on prognostic of resected gallbladder carcinoma.

Authors:  Sergio Renato Pais-Costa; José Francisco de Matos Farah; Ricardo Artigiani-Neto; Sandro José Martins; Alberto Goldenberg
Journal:  Arq Bras Cir Dig       Date:  2014 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.